Role of the Neuropathology of Alzheimer Disease in Dementia in the Oldest-Old
2008/09/01 by Vahram Haroutunian, Michal Schnaider-Beeri, Michal Schnaider Beeri +9 · 27 citations
Medicine · Neuroscience · #Dementia and Cognitive Impairment Research #Alzheimer's disease research and treatments #Neurological Disorders and Treatments
paper · doi:10.1001/archneur.65.9.1211
Abstract
BACKGROUND: Neuritic plaques (NPs) and neurofibrillary tangles (NFTs) in the brain, especially in the hippocampus, entorhinal cortex, and isocortex, are hallmark lesions of Alzheimer disease and dementia in the elderly. However, this association has not been extensively studied in the rapidly growing population of the very old. OBJECTIVE: To assess the relationship between estimates of cognitive function and NP and NFT pathologic conditions in 317 autopsied persons aged 60 to 107 years. DESIGN: We studied the relationship between severity of dementia and the density of these characteristic lesions of Alzheimer disease in young-old, middle-old, and oldest-old persons. The relationship of the severity of dementia as measured by the Clinical Dementia Rating scale to the density of NPs and NFTs was then assessed in each age group. PARTICIPANTS: Three hundred seventeen brains of persons aged 60 years and older were selected to have either no remarkable neuropathological lesions or only NP and NFT lesions. Brains with any other neuropathological conditions, either alone or in addition to Alzheimer disease findings, were excluded. The study cohort was then stratified into the youngest quartile (aged 60-80 years), middle 2 quartiles (aged 81-89 years), and oldest quartile (aged 90-107 years). RESULTS: While the density of NPs and NFTs rose significantly by more than 10-fold as a function of the severity of dementia in the youngest-old group, significant increases in the densities of NPs and NFTs were absent in the brains of the oldest-old. This lack of difference in the densities of NPs and NFTs was due to reduced lesion densities in the brains of oldest-old persons with dementia rather than to increased density of these lesions in the brains of nondemented oldest-old persons. CONCLUSIONS: These findings suggest that the neuropathological features of dementia in the oldest-old are not the same as those of cognitively impaired younger-old persons and compel a vigorous search for neuropathological indices of dementia in this most rapidly growing segment of the elderly population.
Cited by
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- Review: Astrocytes in Alzheimer's disease and other age‐associated dementias: a supporting player with a central role
- Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease. [europepmc]
- Neuropathology of Alzheimer's disease. [europepmc]
- Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project. [europepmc]
- Prevalence of health conditions and predictors of mortality in oldest old Mexican Americans and non-Hispanic whites. [europepmc]
- Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. [europepmc]
- Engaging in cognitive activities, aging, and mild cognitive impairment: a population-based study. [europepmc]
- Validity, reliability, and feasibility of clinical staging scales in dementia: a systematic review. [europepmc]
- A population-based clinicopathological study in the oldest-old: the 90+ study. [europepmc]
- Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. [europepmc]
- Dementia from Alzheimer disease and mixed pathologies in the oldest old. [europepmc]
- Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. [europepmc]
- Neuropathologic basis of age-associated brain atrophy. [europepmc]
- In vivo assessment of amyloid-β deposition in nondemented very elderly subjects. [europepmc]
- Dementia in the oldest old: a multi-factorial and growing public health issue. [europepmc]
- Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. [europepmc]
- Is synaptic loss a unique hallmark of Alzheimer's disease? [europepmc]
- PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. [europepmc]
- Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease. [europepmc]
- Neuropathological and transcriptomic characteristics of the aged brain. [europepmc]
- Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. [europepmc]
- Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference? [europepmc]
- Early-Onset Alzheimer's Disease: What Is Missing in Research? [europepmc]
- Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities. [europepmc]
- The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer's Disease: New Potential Treatment Target. [europepmc]
- Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical Neurologist. [europepmc]
Related